Jazz Pharmaceuticals
JAZZ
357 hedge funds and large institutions have $8.94B invested in Jazz Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 76 funds opening new positions, 126 increasing their positions, 120 reducing their positions, and 36 closing their positions.
111% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 36
25% more funds holding in top 10
Funds holding in top 10: 12 → 15 (+3)
10% more funds holding
Funds holding: 325 → 357 (+32)
5% more repeat investments, than reductions
Existing positions increased: 126 | Existing positions reduced: 120
4% more capital invested
Capital invested by funds: $8.58B → $8.94B (+$355M)
27% less call options, than puts
Call options by funds: $86.4M | Put options by funds: $119M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
+$71.4M |
| 2 |
State Street
Boston,
Massachusetts
|
+$53M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$49.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$43.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$34.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$119M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$53.3M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$43.9M |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
-$31.6M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$23.3M |
JAZZ Hedge Fund Activity: Q4 2014 in Review
357 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Jazz Pharmaceuticals (JAZZ) for Q4 2014, worth a combined $8.94B — up 4.1% from $8.58B a quarter earlier.
Buyers outnumbered sellers: 76 funds opened new JAZZ positions and 36 closed out — a net gain of 40 holders — while 126 added to existing stakes and 120 trimmed.
The largest buyer was American Century Companies, adding an estimated $71.4M. The largest seller was Wells Fargo, cutting an estimated $119M.
- 357 institutional investors held Jazz Pharmaceuticals (JAZZ) as of Q4 2014, up from 325 in Q3 2014.
- Funds reported $8.94B of Jazz Pharmaceuticals stock for Q4 2014, up 4.1% quarter-over-quarter.
- 76 funds opened new Jazz Pharmaceuticals positions in Q4 2014 and 36 closed out, a net change of +40 holders.
- The largest Jazz Pharmaceuticals buyer in Q4 2014 was American Century Companies, an estimated $71.4M added.
- The largest Jazz Pharmaceuticals seller in Q4 2014 was Wells Fargo, an estimated $119M sold.
Based on aggregated 13F filings for Q4 2014.